BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 22530912)

  • 1. Synthesis and biological evaluation of a series of 6,7-dimethoxy-1-(3,4-dimethoxybenzyl)-2-substituted tetrahydroisoquinoline derivatives.
    Zou ZH; Lan XB; Tang CL; Zhu XY; Liu BM; Qian H; Huang WL; Li YM
    Med Chem; 2012 Jul; 8(4):711-6. PubMed ID: 22530912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of furoxan-based nitric oxide-releasing derivatives of tetrahydroisoquinoline as anticancer and multidrug resistance reversal agents.
    Zou ZH; Lan XB; Qian H; Huang WL; Li YM
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5934-8. PubMed ID: 21843940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and synthesis of tetrahydroisoquinoline derivatives as potential multidrug resistance reversal agents in cancer.
    Li Y; Zhang HB; Huang WL; Li YM
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3652-5. PubMed ID: 18502125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of LBM-A5 derivatives as potent P-glycoprotein-mediated multidrug resistance inhibitors.
    Wu Y; Pan M; Dai Y; Liu B; Cui J; Shi W; Qiu Q; Huang W; Qian H
    Bioorg Med Chem; 2016 May; 24(10):2287-97. PubMed ID: 27073052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, cytotoxicity and QSAR study of N-tosyl-1,2,3,4-tetrahydroisoquinoline derivatives.
    Pingaew R; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
    Arch Pharm Res; 2013 Sep; 36(9):1066-77. PubMed ID: 23604819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives as sigma-2 receptor ligands.
    Sun YT; Wang GF; Yang YQ; Jin F; Wang Y; Xie XY; Mach RH; Huang YS
    Eur J Med Chem; 2018 Mar; 147():227-237. PubMed ID: 29438891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
    Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
    J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and multidrug resistance reversal activity of 1,2-disubstituted tetrahydroisoquinoline derivatives.
    Mihályi A; Gáspár R; Zalán Z; Lázár L; Fülöp F; de Witte PA
    Anticancer Res; 2004; 24(3a):1631-6. PubMed ID: 15274333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery to solve multidrug resistance: Design, synthesis, and biological evaluation of novel agents.
    Qiu Q; Shi W; Zhao S; Zhu Y; Ding Z; Zhou S; Kairuki M; Huang W; Qian H
    Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900127. PubMed ID: 31441108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline amides and corresponding ester isosteres as multidrug resistance reversers.
    Braconi L; Bartolucci G; Contino M; Chiaramonte N; Giampietro R; Manetti D; Perrone MG; Romanelli MN; Colabufo NA; Riganti C; Dei S; Teodori E
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):974-992. PubMed ID: 32253945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6,7-Dimethoxy-2-{2-[4-(1H-1,2,3-triazol-1-yl)phenyl]ethyl}-1,2,3,4-tetrahydroisoquinolines as superior reversal agents for P-glycoprotein-mediated multidrug resistance.
    Liu B; Qiu Q; Zhao T; Jiao L; Li Y; Huang W; Qian H
    ChemMedChem; 2015 Feb; 10(2):336-44. PubMed ID: 25470220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of tetrahydroisoquinoline analogues 3-epi-jorumycin and 3-epi-renieramycin G.
    Lane JW; Estevez A; Mortara K; Callan O; Spencer JR; Williams RM
    Bioorg Med Chem Lett; 2006 Jun; 16(12):3180-3. PubMed ID: 16632360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological evaluation of 1-phenyl-1,2,3,4-dihydroisoquinoline compounds as tubulin polymerization inhibitors.
    Zheng CH; Chen J; Liu J; Zhou XT; Liu N; Shi D; Huang JJ; Lv JG; Zhu J; Zhou YJ
    Arch Pharm (Weinheim); 2012 Jun; 345(6):454-62. PubMed ID: 22415658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives as aminopeptidase N/CD13 inhibitors.
    Zhang X; Zhang J; Zhang L; Feng J; Xu Y; Yuan Y; Fang H; Xu W
    Bioorg Med Chem; 2011 Oct; 19(20):6015-25. PubMed ID: 21911297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric Synthesis and Cytotoxicity Evaluation of Right-Half Models of Antitumor Renieramycin Marine Natural Products.
    Matsubara T; Yokoya M; Sirimangkalakitti N; Saito N
    Mar Drugs; 2018 Dec; 17(1):. PubMed ID: 30577460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and evaluation of novel triazole core based P-glycoprotein-mediated multidrug resistance reversal agents.
    Jiao L; Qiu Q; Liu B; Zhao T; Huang W; Qian H
    Bioorg Med Chem; 2014 Dec; 22(24):6857-66. PubMed ID: 25464884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Synthesis of Tetrahydroisoquinoline Derivatives as Anti-Angiogenesis and Anti-Cancer Agents.
    Gangapuram M; Eyunni S; Zhang W; Redda KK
    Anticancer Agents Med Chem; 2021; 21(18):2505-2511. PubMed ID: 33438560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.
    Sim S; Lee S; Ko S; Phuong Bui B; Linh Nguyen P; Cho J; Lee K; Kang JS; Jung JK; Lee H
    Bioorg Med Chem; 2021 Sep; 46():116371. PubMed ID: 34500188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Biological Evaluation, and Molecular Modeling of Tetrahydroisoquinoline Derivatives: Discovery of A Potent P-Glycoprotein Ligand Overcoming Multidrug Resistance in Cancer Stem Cells.
    Riganti C; Contino M; Guglielmo S; Perrone MG; Salaroglio IC; Milosevic V; Giampietro R; Leonetti F; Rolando B; Lazzarato L; Colabufo NA; Fruttero R
    J Med Chem; 2019 Jan; 62(2):974-986. PubMed ID: 30584838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-Activity Relationship Studies on 6,7-Dimethoxy-2-phenethyl-1,2,3,4-tetrahydroisoquinoline Derivatives as Multidrug Resistance Reversers.
    Teodori E; Dei S; Bartolucci G; Perrone MG; Manetti D; Romanelli MN; Contino M; Colabufo NA
    ChemMedChem; 2017 Aug; 12(16):1369-1379. PubMed ID: 28570027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.